imipramine has been researched along with Cutaneous Mastocytosis in 2 studies
Imipramine: The prototypical tricyclic antidepressant. It has been used in major depression, dysthymia, bipolar depression, attention-deficit disorders, agoraphobia, and panic disorders. It has less sedative effect than some other members of this therapeutic group.
imipramine : A dibenzoazepine that is 5H-dibenzo[b,f]azepine substituted by a 3-(dimethylamino)propyl group at the nitrogen atom.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| DOMENJOZ, R | 1 |
| SCHELLENBERG, H | 2 |
2 other studies available for imipramine and Cutaneous Mastocytosis
| Article | Year |
|---|---|
[Pharmacological studies on 5-hydroxytryptamine metabolism in mastocytoma].
Topics: Chlorpromazine; Dihydroxyphenylalanine; Imipramine; Iproniazid; Isocarboxazid; Mastocytoma; Mastocyt | 1962 |
[Effect of chlorpromazine and imipramine on the respiration and anaerobic glycolysis of mastocytoma P-815 and Ehrlich ascites tumor].
Topics: Animals; Carbohydrate Metabolism; Carbohydrates; Carcinoma, Ehrlich Tumor; Chlorpromazine; Glycolysi | 1961 |